On the flip side

Ebb & Flow

On the flip side

Investors are often advised to buy and hold stocks they like. But a review of stock price behavior around FDA advisory panel meetings shows that such strategies aren't always rewarded. Judging from the trading histories of 19 companies that have had FDA panel meetings going back to September 1995, investors are selling immediately after the actual event, even if the news is good.

"People are selling on

Read the full 742 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE